Glandokort
Longevity & Cellular HealthAlso known as: Adrenal Bioregulator, Khavinson Adrenal Peptide, Adrenal Gland Bioregulator
Mechanism
Glandokort is a peptide bioregulator for the adrenal glands — the small organs on top of your kidneys that produce cortisol, adrenaline, DHEA, and aldosterone. These hormones control your stress response, energy levels, blood pressure, and immune function. With age, adrenal function gradually declines (sometimes called "adrenal fatigue" in alternative medicine, though this remains debated). Glandokort aims to restore proper adrenal gene expression, supporting balanced cortisol rhythms and hormonal output without directly providing hormones.
Technical detail
Glandokort is a short-chain peptide bioregulator from the Khavinson series targeting adrenal cortex and medulla cells. Proposed mechanism: interaction with nuclear DNA in adrenocortical cells to modulate expression of steroidogenic enzymes including StAR (steroidogenic acute regulatory protein), CYP11A1 (cholesterol side-chain cleavage), CYP21A2 (21-hydroxylase), and CYP11B1/B2 (cortisol and aldosterone synthesis). May normalize HPA axis feedback sensitivity by modulating glucocorticoid receptor (GR/NR3C1) expression in adrenal tissue. In the adrenal medulla, may support catecholamine synthesis enzyme expression (tyrosine hydroxylase, PNMT). Consistent with Khavinson theory: chromatin remodeling in age-decondensed or hypercondensed regions to restore youthful gene expression patterns. Limited published data — primarily from Khavinson group publications.
Effects
ENDOCRINE: Primary target system. Adrenal glands produce three classes of hormones: (1) Glucocorticoids (cortisol) — stress response, immune modulation, glucose regulation; (2) Mineralocorticoids (aldosterone) — sodium/potassium balance, blood pressure; (3) Androgens (DHEA, DHEA-S, androstenedione) — the "youth hormones" that decline dramatically with age. Adrenal cortex has three functional zones: zona glomerulosa (aldosterone), zona fasciculata (cortisol), zona reticularis (DHEA). DHEA-S peaks at age 20-25 and declines ~2% per year, reaching 10-20% of peak levels by age 70 — the most dramatic age-related hormone decline (called "adrenopause"). Glandokort targets adrenal cortex cells to normalize steroidogenic enzyme expression: StAR (cholesterol transport into mitochondria), CYP11A1 (side-chain cleavage), CYP17A1 (17-hydroxylase/17,20-lyase for DHEA), CYP21A2 and CYP11B1/B2 (cortisol and aldosterone synthesis). May normalize HPA axis feedback by modulating glucocorticoid receptor (GR) expression in adrenal tissue. IMMUNE: Cortisol is the body's primary anti-inflammatory hormone. Normalized cortisol rhythms (high morning, low evening) support appropriate immune regulation. Chronic stress causes cortisol dysregulation → immune suppression. DHEA has direct immunomodulatory effects — enhances Th1 responses. NEUROLOGICAL: DHEA and DHEA-S are neurosteroids — they modulate GABA-A and NMDA receptors. Adrenal androgens support mood, cognition, and resilience. Cortisol dysregulation (chronic elevation) damages hippocampal neurons. CARDIOVASCULAR: Aldosterone regulates blood pressure via renal sodium reabsorption. Adrenal androgen deficiency is associated with increased cardiovascular mortality. METABOLIC: Cortisol regulates glucose (gluconeogenesis), protein catabolism, and fat distribution. Adrenal dysfunction contributes to metabolic syndrome. MUSCULOSKELETAL: DHEA is an anabolic hormone precursor — supports muscle mass and bone density. Cortisol excess causes muscle wasting and osteoporosis. Tier 3: Users report improved stress resilience, better sleep quality, more stable energy throughout the day, and improved recovery from physical and emotional stress. Often used by people with signs of adrenal fatigue/HPA axis dysregulation.
Practitioner Guide
DOSING TIPS: Standard protocol: 1-2 capsules daily for 10-30 days, repeated every 3-6 months. For stress recovery: 2 capsules daily for 30 days. Take in the morning to align with natural cortisol rhythm. SUPPLEMENT SYNERGIES: Adaptogenic herbs — ashwagandha (300-600mg KSM-66), rhodiola (200-400mg standardized extract), holy basil — support HPA axis alongside bioregulator. Vitamin C (1000-2000mg/day) — adrenal glands have the highest vitamin C concentration in the body; depleted by stress. Pantothenic acid (B5, 500mg/day) — essential cofactor for adrenal steroid synthesis. Magnesium glycinate (400mg before bed) — supports parasympathetic recovery and cortisol clearance. Phosphatidylserine (300-400mg at bedtime) — shown to blunt excessive cortisol in stressed individuals. DHEA supplementation (10-25mg/day for women, 25-50mg for men) if labs confirm low levels. CYCLING: Standard Khavinson protocol. CONTRAINDICATION NUANCES: Cushing's syndrome (cortisol-producing adrenal tumor) — do not stimulate adrenal gene expression. Addison's disease — may complement but cannot replace cortisol replacement therapy. Patients on hydrocortisone/prednisone — monitor for changes in cortisol dynamics. Patients with adrenal incidentalomas — evaluate with endocrinologist first. STORAGE: Room temperature. PATIENT EDUCATION: Your adrenal glands are your body's stress response system. They produce cortisol (stress hormone), DHEA (youth hormone), and aldosterone (blood pressure hormone). This bioregulator aims to help these glands produce the right amounts at the right times. It is not a cortisol supplement or DHEA replacement. Best used alongside stress management practices (sleep, meditation, exercise). Get baseline labs: morning cortisol, DHEA-S, aldosterone, and ACTH.
Research Summary
TIER 1 (Gold Standard): No Western clinical trials specific to Glandokort. TIER 2 (Strong): Khavinson bioregulation theory. Adrenal aging (adrenopause) well-characterized — DHEA-S decline is one of the most robust biomarkers of aging (Orentreich et al., JCEM). HPA axis dysregulation in chronic stress — extensive literature. TIER 3 (Moderate): Khavinson group adrenal bioregulator publications. Practitioner reports. Community experience. KEY FINDINGS: (1) Adrenal function is a compelling bioregulator target due to age-related DHEA decline. (2) No independent validation. (3) HPA axis is well-understood, making the theoretical basis stronger than some other bioregulators. GAPS: Standard Khavinson gaps apply.